News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

Opinion|Videos|March 18, 2025

Overview of IUD Mechanisms and Barriers to Use

Author(s)Lisa Bayer, MD, MPH

Panelists discuss how intrauterine device (IUD) usage rates are increasing but remain low despite the availability of hormonal and new copper options. Obstacles include physician education gaps, patient anxieties about procedures, high up-front costs (especially for the uninsured), and misconceptions about fertility risks that modern IUDs do not pose.

Episodes in this series

1 expert is featured in this series.

EP. 1 Understanding the Rates of Unplanned Pregnancy in the United States

1 expert is featured in this series.

EP. 2 Overview of IUD Mechanisms and Barriers to Use

1 expert is featured in this series.

EP. 3 Reducing Anxieties of IUD Placement

1 expert is featured in this series.

EP. 4 Empowering Patients and Addressing Concerns in IUD Placement

1 expert is featured in this series.

EP. 5 Addressing the Patient/Provider Disconnect in Reported Pain

1 expert is featured in this series.

EP. 6 Managing Patient Experiences During and After IUD Placement

Video content above is prompted by the following:

Approved IUD options with various mechanisms of action, such as hormonal
New copper option available
Two-thirds of women between teens and age 49 years are using contraception; the IUD rate has increased (but is still low).
Obstacles such as physician education, the anxieties of a procedure, and various other factors out of their control leave patients worried.
IUDs can be expensive up front, especially for those who are uninsured.
Modern IUDs do not come with fertility risks.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

Sarah McLeod, PhD

Sarah McLeod, PhD, discusses high cure rates with zoliflodacin for uncomplicated gonorrhea

BySarah McLeod, PhD

October 28th 2025

Special Report: Managing vasomotor symptoms in menopause | Image credit: Contemporary OB/GYN

Special Report: Future research outlook

ByJoAnn V. Pinkerton, MD,Jill Liss, MD, MSCP, FACOG

October 27th 2025

Special Report: Managing vasomotor symptoms in menopause | Image credit: Contemporary OB/GYN

Special Report: Positioning emerging treatments relative to established options

ByJoAnn V. Pinkerton, MD,Jill Liss, MD, MSCP, FACOG

October 27th 2025

Special Report: Managing vasomotor symptoms in menopause | Image credit: Contemporary OB/GYN

Special Report: How neurokinin receptor antagonists are reshaping the VMS treatment landscape

ByJoAnn V. Pinkerton, MD,Jill Liss, MD, MSCP, FACOG

October 27th 2025

Special Report: Managing vasomotor symptoms in menopause | Image credit: Contemporary OB/GYN

Special Report: Recent advancements in pharmacologic and nonpharmacologic treatment options

ByJoAnn V. Pinkerton, MD,Jill Liss, MD, MSCP, FACOG

October 27th 2025

Latest CME

‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis

‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis

Raj Chovatiya, MD, PhD, MSCI, FAAD; Michael Rubio, PA-C, MMSc

Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances

Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances

Kathleen N. Moore, MD, MS, FASCO; Susana Banerjee, MBBS, MA, FRCP, PhD; David M. O’Malley, MD; Ritu Salani, MD, MBA

Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care

Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care

Kathleen N. Moore, MD, MS, FASCO; Ritu Salani, MD, MBA

Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials

Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials

Kathleen N. Moore, MD, MS, FASCO; Prof Susana Banerjee, MBBS, MA, FRCP, PhD

Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer

Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer

Kathleen N. Moore, MD, MS, FASCO; David M. O’Malley, MD

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations

John Brandsema, MD; Neelam Goyal, MD

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Rachel N. Grisham, MD; Domenica Lorusso, MD, PhD

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Rebecca Shatsky, MD; Kelly McCann, MD, PhD; Michelle L. Taylor, ANP-BC

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Jill Alldredge, MD; Emely Alfaro, MS, RN, CNS, OCN

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Emely Alfaro, MS, RN, CNS, OCN; Jill Alldredge, MD

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

Trending on Contemporary OB/GYN

Natasha Spencer, MD, highlights advances in obstetric management

Contaminated meat linked to 1 in 5 UTIs in Southern California

© 2025 MJH Life Sciences^®

All rights reserved.